NIOX Competitors and Similar CompaniesClear all
Affimed N.V.'s competitors and similar companies include Sucampo Pharmaceuticals.
 Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. |  Sucampo Pharmaceuticals Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis. | |
Founding Date | Founding Date 2000 | Founding Date 1996 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Heidelberg, DE HQ | Locations Rockville, US HQ Chiyoda, JP Chuo Ward, JP Kita Ward, JP Sanda Shi, JP Zug, CH Milton, GB |
Employees | Employees 76 | Employees 37 |
Financial | ||
Revenue (est.) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) $230.1m (FY, 2016) |
Cost of goods | Cost of goods N/A | Cost of goods $76m (FY, 2016) |
Gross profit | Gross profit €13m (FY, 2023) | Gross profit $154.1m (FY, 2016) |
Net income | Net income (€105.9m) (FY, 2023) | Net income $18.5m (FY, 2016) |
For sources of this data, please see the company profile
View Company Profiles
Sucampo Pharmaceuticals
HQ
Rockville, US
Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.
View company